Module 397

Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets: 10
Num genes: 121 (see 1225 additional genes for this module)
Num experiments: 482 (219 induced, 263 repressed)
Parent module: None
Children modules: 337 320


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
nuclear division
M phase
M phase of mitotic cell cycle
mitotic anaphase
Pyrimidine_metabolism
Ross01 2
Nucleotide Metabolism
primary active transporter activity
P_P_bond_hydrolysis_driven transporter activity
Detweiler01 36


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation Category P-value Hits Hits(%) Module hits in category Arrays in annotation Arrays
Liver tissue (Liver cancer*) Liver cancer* 1.2e-36 92 34.9 263 187 1945
Liver tissue, cancer or cell line (Liver cancer*) Liver cancer* 3.0e-34 92 34.9 263 197 1945
Hepatitis infected liver (Liver cancer*) Liver cancer* 1.2e-26 73 27.7 263 156 1945
Hematologic cancer and cell line (Stimulated PBMC) Stimulated PBMC 3.9e-26 25 100 25 30 182
Macrophages (Stimulated PBMC) Stimulated PBMC 3.9e-26 25 100 25 30 182
Non-tumor liver tissue (Liver cancer) Liver cancer 6.7e-25 68 73.9 92 76 207
Cancer and cell line (Liver cancer) Liver cancer 1.8e-17 66 98.5 67 126 207
Liver tissue, cancer or cell line (Liver cancer*) Liver cancer* 7.7e-16 61 27.9 218 197 1945
Hepatitis infected liver (Liver cancer*) Liver cancer* 1.1e-11 47 21.5 218 156 1945
Liver tissue (Liver cancer*) Liver cancer* 8.3e-11 51 23.3 218 187 1945
Normal lung tissue (Lung cancer) Lung cancer 4.7e-09 16 32 50 22 276
Normal tissue (Lung cancer) Lung cancer 1.3e-08 16 32 50 23 276
Cancer (Liver cancer) Liver cancer 5.0e-08 55 82.0 67 115 207
Cell line (Liver cancer) Liver cancer 2.2e-06 11 16.4 67 11 207
Invasive liver tumor (Liver cancer) Liver cancer 2.7e-06 25 37.3 67 38 207
Adenocarcinoma (Liver cancer) Liver cancer 2.9e-06 47 70.1 67 97 207
Hepatocellular carcinoma (Liver cancer) Liver cancer 3.9e-06 49 73.1 67 104 207
Normal tissue (Liver cancer) Liver cancer 6.4e-06 14 15.2 92 14 207
Cancer and cell line (Breast cancer*) Breast cancer* 6.7e-06 34 15.5 218 143 1945
Liver cancer cell line (Liver cancer) Liver cancer 7.7e-06 10 14.9 67 10 207
B. petrussis A2 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 1.2e-05 5 29.4 17 5 144
B. petrussis Tox 6 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 1.2e-05 5 29.4 17 5 144
B. petrussis stimulated immune cells (Stimulated PBMC) Stimulated PBMC 1.7e-05 16 94.1 17 67 144
Stimulated B cells (B lymphoma) B lymphoma 2.7e-05 7 28 25 12 245
Hematologic samples (B lymphoma) B lymphoma 5.8e-05 9 36 25 22 245
Cell line (B lymphoma) B lymphoma 6.3e-05 6 37.5 16 14 245
Small cell lung cancer (Lung cancer) Lung cancer 8.1e-05 6 22.2 27 10 276
Breast cancer or cell line (Breast cancer*) Breast cancer* 9.1e-05 29 13.3 218 128 1945
Cell line (Breast cancer) Breast cancer 0.0001 15 44.1 34 30 152
Normal lymphocytes (B lymphoma) B lymphoma 0.0002 10 40 25 31 245
Gram negative bacteria stimulated immune cells (Stimulated PBMC) Stimulated PBMC 0.0002 16 94.1 17 78 144


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation P-value Hits Hits(%) Module genes Genes in annotation Genes
M phase of mitotic cell cycle 2.1e-12 8 16.3 49 17 4566
M phase 2.3e-12 9 18.3 49 26 4566
nuclear division 1.1e-11 8 16.3 49 20 4566
mitosis 5.7e-11 10 20.4 49 50 4566
mitotic cell cycle 7.0e-11 10 20.4 49 51 4566
cell cycle 7.8e-10 13 26.5 49 135 4566
mitotic anaphase 5.0e-08 5 10.2 49 11 4566
regulation of cell cycle 6.2e-06 10 20.4 49 163 4566
viral host cell process manipulation 9.9e-06 8 16.3 49 102 4566
DNA replication and chromosome cycle 1.1e-05 5 10.2 49 29 4566
regulation of transcription 1.3e-05 7 14.2 49 76 4566
spindle 1.4e-05 4 8.1 49 15 4566
transcription\, DNA-dependent 5.4e-05 9 18.3 49 167 4566
transcription 0.0001 9 18.3 49 184 4566


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Visual display
Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.
You can also view the images within GeneXPress by loading the module gxp file file.
Note: Since there are 482 experiments, this image does not display the individual experiment names, but rather condenses each experiment to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above
 
 





 >4x